Short chains
of amino acid monomers which are linked by amide bonds are termed as peptides.
Peptides are different from proteins due to difference in their sizes. Peptides
contain less than 50 molecules of amino acids. Peptides bind themselves to some
specific cell surface receptors and imitate like receptor ligands. This
characteristic of peptides helps in treating various diseases as peptides act
on the cell membrane. Increasing number of cancer patients and various
metabolic diseases as well as technological advancements such as introduction
of hybrid method of synthesis of peptides, are expected to drive the peptide
therapeutics market over the forecast period. Huge market potential has been
identified in peptide therapeutics market globally and thus various
pharmaceutical and biotechnology industries are actively investing in research
& development activities to develop newer peptides to be used for various
applications. Cancer has been a major cause of death globally. According to
world health organisation (WHO), number of cancer patients is expected to
increase from 12.7 million per year in 2011 to 16 million per year in 2020.
Increase in
metabolic diseases such as diabetes, along with increase in number of cancer
patients is expected to boost the market for peptide therapeutics. Continuous
R&D in peptide therapeutics has developed various technologies and routes
of administration of peptides. However, the conventional route of
administration which is parenteral route has grabbed maximum share in terms of
revenue of total market share of peptides by route of administration in 2013.
Technology market was dominated by long phase peptide synthesis (SPSS) of total
market share in 2013. Peptide therapeutics market can be classifies on the
basis of technology used, application, route of administration and product of
peptides. North America holds largest market share while Asia Pacific region is
expected to grow at a significant rate over next six years. Key market
participants for this market include Roche, Novo-Nordisk, Bachem, Lonza, Eli
Lilly, Amylin, Ipsen, Polypeptide Group, Peptisyntha etc.
Key
technology segments analysed in this report include solid phase peptide
synthesis (SPPS), liquid phase peptide synthesis (LPPS) and hybrid phase
peptide synthesis (HPSS). SPSS technology segment dominated the overall peptide
therapeutics market in terms of revenue in 2013. Due to introduction of newer
technologies like HPSS, market share of SPSS is expected to reduce by 2020.
HPSS is the fastest growing technological segment over the forecast period.
To request a
sample copy or view summary of this report, click the link below:
Key
applications of peptide therapeutics reviewed in this report include cancer,
metabolic, cardiovascular, dermatology, anti-infection, gastro intestinal,
renal, respiratory, pain and others. Use of Peptide Therapeutics for treatment
of cancer has captured most of the market share of total ablation market in
2013. Increase in numbers of cancer patients has driven the market growth.
Increasing awareness about Peptide Therapeutics for treatment of cancer is
expected to fuel the market to grow. Use of Peptide Therapeutics for treatment
of cancer was followed by metabolicapplications.
Key routes
of administration of peptide therapeutics analysed in this report include
parenteral route, oral route, pulmonary route, mucosal route and other routes
such as intradermal route & nasal route. Traditional route of
administration, parenteral route has captured most of the market share as it
has been used for a long time. Higher comfort level of patients with parenteral
route is expected to fuel the market growth over the forecast period.
This report
analyses the peptide therapeutics market by products of peptides as innovative
and generic. Innovative peptides dominated the total market share in 2013 in
terms of revenue owing to their higher prices than the generic peptides.
Technological advancement is also expected to fuel the growth of innovative
product segment during the forecast period.
North
America holds maximum market share of total peptide therapeutics market in
terms of revenue in 2013. North America was followed by Europe. Higher
awareness about medication and available treatments has helped this market to
grow in North America and Europe. Economic recession has affected the market
growth on these regions negatively. Asia Pacific region has observed a
significant growth rate over last two years and is expected to grow at the same
rate over the forecast period owing to increasing disposable income of
patients. Developing economies like India and China are expected to fuel the market
growth over the forecast period. Peptide therapeutics market is expected to
grow at a relatively sluggish rate in Europe and North America.
About
Grand View Research:
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web:
www.grandviewresearch.com
